Nine- to Twelve-Month Anti-Tuberculosis Treatment Is Associated with a Lower Recurrence Rate than 6–9-Month Treatment in Human Immunodeficiency Virus-Infected Patients: A Retrospective Population-Based Cohort Study in Taiwan

BACKGROUND: Human immunodeficiency virus (HIV)-infected patients are at an increased risk of tuberculosis (TB) and its recurrence following completion of anti-TB treatment. We investigated whether extending anti-TB treatment to 9 months or longer reduces TB recurrence. METHODS: HIV-infected patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jann-Yuan, Sun, Hsin-Yun, Wang, Jann-Tay, Hung, Chien-Ching, Yu, Ming-Chih, Lee, Chih-Hsin, Lee, Li-Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669121/
https://www.ncbi.nlm.nih.gov/pubmed/26633835
http://dx.doi.org/10.1371/journal.pone.0144136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669121/
https://www.ncbi.nlm.nih.gov/pubmed/26633835
http://dx.doi.org/10.1371/journal.pone.0144136

Ejemplares similares